Clinical Genitourinary Cancer

杂志介绍

Clinical Genitourinary Cancer杂志介绍

《Clinical Genitourinary Cancer》是一本以English为主的未开放获取国际优秀期刊，中文名称临床泌尿生殖系癌，本刊主要出版、报道医学-ONCOLOGY领域的研究动态以及在该领域取得的各方面的经验和科研成果，介绍该领域有关本专业的最新进展，探讨行业发展的思路和方法，以促进学术信息交流，提高行业发展。该刊已被国际权威数据库SCIE收录，为该领域相关学科的发展起到了良好的推动作用，也得到了本专业人员的广泛认可。该刊最新影响因子为2.3，最新CiteScore 指数为5.2。

本刊近期中国学者发表的论文主要有：

• DNA Methylation Architecture Provides Insight into the Pathogenesis of Upper Tract Urothelial Carcinoma: A Systematic Review and Meta-Analysis

  Author: Lin, Yifei; Lin, Ling; Yang, Yong; Li, Mei; Jiang, Xin; Fu, Tingting; Long, Youlin; Guo, Qiong; He, He; Chen, Zhenglong; Du, Liang; Liao, Ga; Liao, Banghua; Huang, Jin

• Renal Cell Carcinoma Associated with t (6;11) Translocation/TFEB Gene Fusion: A Case Report and Review of Literature

  Author: Wang, Yiming; Xu, Guangjun; Yang, Haitao; Zhou, Xiaolong; Wen, Haitao

• Elevated Expression of ADAP2 is Associated With Aggressive Behavior of Human Clear-Cell Renal Cell Carcinoma and Poor Patient Survival

  Author: Qiang, Yuanyuan; Wang, Xuhui; Ding, Jiangwei; Wang, Ziqin; Li, Bianli; Ji, Hui; Zhang, Xue; Yang, Yong; Liu, Kunmei; Zhang, Lianxiang; Ma, Shengmao; Zhao, Di; Lu, Guangyuan

• Surgical Management and Oncologic Outcomes for Local Retroperitoneal Recurrence of Renal Cell Carcinoma After Radical Nephrectomy

  Author: Huang, Jiwei; Wang, Yueming; Zhang, Cuijian; Hu, Xiaoyi; Wang, Ping; Shi, Guohai; Dong, Liang; Zhang, Jin; Kong, Wen; Chen, Yonghui; Xia, Dan; Guo, Jianming; Xue, Wei; Huang, Yiran; He, Zhisong

英文介绍

Clinical Genitourinary Cancer杂志英文介绍

Clinical Genitourinary Cancer is a peer-reviewed journal that publishes original articles describing various aspects of clinical and translational research in genitourinary cancers. Clinical Genitourinary Cancer is devoted to articles on detection, diagnosis, prevention, and treatment of genitourinary cancers. The main emphasis is on recent scientific developments in all areas related to genitourinary malignancies. Specific areas of interest include clinical research and mechanistic approaches; drug sensitivity and resistance; gene and antisense therapy; pathology, markers, and prognostic indicators; chemoprevention strategies; multimodality therapy; and integration of various approaches.